Paloma Partners Management CO Arbutus Biopharma Corp Transaction History

Paloma Partners Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.98 - $3.17 $37,576 - $60,160	-18,978 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.42 - $3.98 $15,601 - $25,659	6,447 Added 51.45%	18,978 $57,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $38,971 - $57,767	12,531 New	12,531 $49,000
Q1 2020 May 15, 2020	SELL	$1.01 - $3.42 $19,870 - $67,285	-19,674 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.87 - $2.89 $17,116 - $56,857	19,674 New	19,674 $55,000
Q3 2019 Nov 14, 2019	SELL	$1.34 - $2.4 $210,782 - $377,520	-157,300 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.46 - $4.44 $229,658 - $698,412	157,300 New	157,300 $327,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.